Follow the people · Insider
Dominic Piscitelli
Dominic Piscitelli files insider transactions with the SEC as a chief financial officer of Oric Pharmaceuticals (ORIC). We hold 2 disclosed purchases and sales filed since 28 February 2017, 1 of them in the last 90 days.
- Files forORIC
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure28 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 23 April 2020 — 26 August 2026Chief Financial Officer · Oric Pharmaceuticals (ORIC)65 Form 4 lines · source: SEC Form 4
- Filed 24 February 2017 — 8 February 2019Chief Financial Officer · Anaptysbio (ANAB)11 Form 4 lines · source: SEC Form 4
Everything they disclosed
76 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 52,000 shares of Oric PharmaceuticalsSEC Form 428 August 2026Common Stock · traded 26 August 2026 · filed 28 August 2026
- exercised options over 25,000 shares of Oric PharmaceuticalsSEC Form 428 August 2026Common Stock · traded 26 August 2026 · filed 28 August 2026
- ▼ sold on the open market 77,000 shares of Oric PharmaceuticalsSEC Form 428 August 2026Common Stock · traded 26 August 2026 · filed 28 August 2026
- exercised options over 52,000 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 428 August 2026Stock Option (right to buy) · traded 26 August 2026 · filed 28 August 2026
- exercised options over 25,000 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 428 August 2026Stock Option (right to buy) · traded 26 August 2026 · filed 28 August 2026
- exercised options over 52,000 shares of Oric PharmaceuticalsSEC Form 426 February 2026Common Stock · traded 24 February 2026 · filed 26 February 2026
- ▼ sold on the open market 52,000 shares of Oric PharmaceuticalsSEC Form 426 February 2026Common Stock · traded 24 February 2026 · filed 26 February 2026
- exercised options over 52,000 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 426 February 2026Stock Option (right to buy) · traded 24 February 2026 · filed 26 February 2026
- exercised options over 52,000 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 426 February 2026Stock Option (right to buy) · traded 24 February 2026 · filed 26 February 2026
- exercised options over 52,000 shares of Oric PharmaceuticalsSEC Form 426 February 2026Common Stock · traded 24 February 2026 · filed 26 February 2026
- ▼ sold on the open market 52,000 shares of Oric PharmaceuticalsSEC Form 426 February 2026Common Stock · traded 24 February 2026 · filed 26 February 2026
- was granted 206,500 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 46 January 2026Stock Option (right to buy) · traded 2 January 2026 · filed 6 January 2026
- was granted 34,500 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 46 January 2026Restricted Stock Unit · traded 2 January 2026 · filed 6 January 2026
- was granted 206,500 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 46 January 2026Stock Option (right to buy) · traded 2 January 2026 · filed 6 January 2026
- was granted 34,500 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 46 January 2026Restricted Stock Unit · traded 2 January 2026 · filed 6 January 2026
- exercised options over 8,000 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 417 December 2025Restricted Stock Unit · traded 15 December 2025 · filed 17 December 2025
- exercised options over 10,000 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 417 December 2025Restricted Stock Unit · traded 15 December 2025 · filed 17 December 2025
- exercised options over 11,333 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 417 December 2025Restricted Stock Unit · traded 15 December 2025 · filed 17 December 2025
- exercised options over 29,333 shares of Oric PharmaceuticalsSEC Form 417 December 2025Common Stock · traded 15 December 2025 · filed 17 December 2025
- ▼ sold on the open market 10,720 shares of Oric PharmaceuticalsSEC Form 417 December 2025Common Stock · traded 16 December 2025 · filed 17 December 2025
- exercised options over 11,000 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 48 October 2025Stock Option (right to buy) · traded 6 October 2025 · filed 8 October 2025
- exercised options over 11,000 shares of Oric PharmaceuticalsSEC Form 48 October 2025Common Stock · traded 6 October 2025 · filed 8 October 2025
- ▼ sold on the open market 11,000 shares of Oric PharmaceuticalsSEC Form 48 October 2025Common Stock · traded 6 October 2025 · filed 8 October 2025
- ▼ sold on the open market 20,000 shares of Oric PharmaceuticalsSEC Form 42 July 2025Common Stock · traded 1 July 2025 · filed 2 July 2025
- ▼ sold on the open market 584 shares of Oric PharmaceuticalsSEC Form 424 June 2025Common Stock · traded 23 June 2025 · filed 24 June 2025
- ▼ sold on the open market 450 shares of Oric PharmaceuticalsSEC Form 424 June 2025Common Stock · traded 23 June 2025 · filed 24 June 2025
- ▼ sold on the open market 32,466 shares of Oric PharmaceuticalsSEC Form 424 June 2025Common Stock · traded 24 June 2025 · filed 24 June 2025
- ▼ sold on the open market 300 shares of Oric PharmaceuticalsSEC Form 413 June 2025Common Stock · traded 12 June 2025 · filed 13 June 2025
- ▼ sold on the open market 324 shares of Oric PharmaceuticalsSEC Form 411 June 2025Common Stock · traded 10 June 2025 · filed 11 June 2025
- ▼ sold on the open market 1,276 shares of Oric PharmaceuticalsSEC Form 411 June 2025Common Stock · traded 11 June 2025 · filed 11 June 2025
- ▼ sold on the open market 1,700 shares of Oric PharmaceuticalsSEC Form 411 June 2025Common Stock · traded 11 June 2025 · filed 11 June 2025
- ▼ sold on the open market 2,600 shares of Oric PharmaceuticalsSEC Form 49 June 2025Common Stock · traded 6 June 2025 · filed 9 June 2025
- ▼ sold on the open market 300 shares of Oric PharmaceuticalsSEC Form 49 June 2025Common Stock · traded 9 June 2025 · filed 9 June 2025
- was granted 202,500 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 43 January 2025Stock Option (right to buy) · traded 2 January 2025 · filed 3 January 2025
- was granted 34,000 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 43 January 2025Restricted Stock Unit · traded 2 January 2025 · filed 3 January 2025
- exercised options over 6,042 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 417 December 2024Restricted Stock Unit · traded 15 December 2024 · filed 17 December 2024
- exercised options over 8,000 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 417 December 2024Restricted Stock Unit · traded 15 December 2024 · filed 17 December 2024
- exercised options over 10,000 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 417 December 2024Restricted Stock Unit · traded 15 December 2024 · filed 17 December 2024
- exercised options over 24,042 shares of Oric PharmaceuticalsSEC Form 417 December 2024Common Stock · traded 15 December 2024 · filed 17 December 2024
- ▼ sold on the open market 8,851 shares of Oric PharmaceuticalsSEC Form 417 December 2024Common Stock · traded 16 December 2024 · filed 17 December 2024
- was granted 180,000 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 43 January 2024Stock Option (right to buy) · traded 2 January 2024 · filed 3 January 2024
- was granted 30,000 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 43 January 2024Restricted Stock Unit · traded 2 January 2024 · filed 3 January 2024
- exercised options over 6,042 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 419 December 2023Restricted Stock Unit · traded 15 December 2023 · filed 19 December 2023
- exercised options over 8,000 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 419 December 2023Restricted Stock Unit · traded 15 December 2023 · filed 19 December 2023
- exercised options over 14,042 shares of Oric PharmaceuticalsSEC Form 419 December 2023Common Stock · traded 15 December 2023 · filed 19 December 2023
- ▼ sold on the open market 5,282 shares of Oric PharmaceuticalsSEC Form 419 December 2023Common Stock · traded 15 December 2023 · filed 19 December 2023
- ▼ sold on the open market 2,227 shares of Oric PharmaceuticalsSEC Form 417 February 2023Common Stock · traded 15 December 2022 · filed 17 February 2023
- was granted 145,000 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 42 February 2023Stock Option (right to buy) · traded 1 February 2023 · filed 2 February 2023
- was granted 24,000 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 42 February 2023Restricted Stock Unit · traded 1 February 2023 · filed 2 February 2023
- exercised options over 6,041 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 416 December 2022Restricted Stock Unit · traded 15 December 2022 · filed 16 December 2022
- exercised options over 6,041 shares of Oric PharmaceuticalsSEC Form 416 December 2022Common Stock · traded 15 December 2022 · filed 16 December 2022
- ▼ sold on the open market 2,089 shares of Oric PharmaceuticalsSEC Form 416 December 2022Common Stock · traded 15 December 2022 · filed 16 December 2022
- returned to the issuer 207,500 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 421 July 2022Stock Option (right to buy) · traded 20 July 2022 · filed 21 July 2022
- returned to the issuer 86,250 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 421 July 2022Stock Option (right to buy) · traded 20 July 2022 · filed 21 July 2022
- returned to the issuer 90,000 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 421 July 2022Stock Option (right to buy) · traded 20 July 2022 · filed 21 July 2022
- returned to the issuer 108,750 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 421 July 2022Stock Option (right to buy) · traded 20 July 2022 · filed 21 July 2022
- was granted 207,500 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 421 July 2022Stock Option (right to buy) · traded 20 July 2022 · filed 21 July 2022
- was granted 86,250 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 421 July 2022Stock Option (right to buy) · traded 20 July 2022 · filed 21 July 2022
- was granted 90,000 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 421 July 2022Stock Option (right to buy) · traded 20 July 2022 · filed 21 July 2022
- was granted 108,750 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 421 July 2022Stock Option (right to buy) · traded 20 July 2022 · filed 21 July 2022
- ▲ bought on the open market 60,000 shares of Oric PharmaceuticalsSEC Form 431 March 2022Common Stock · traded 31 March 2022 · filed 31 March 2022
- was granted 108,750 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 42 February 2022Stock Option (right to buy) · traded 1 February 2022 · filed 2 February 2022
- was granted 18,125 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 42 February 2022Restricted Stock Unit · traded 1 February 2022 · filed 2 February 2022
- was granted 90,000 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 42 February 2021Stock Option (right to buy) · traded 1 February 2021 · filed 2 February 2021
- was granted 86,250 shares of Oric Pharmaceuticals (a derivative holding)SEC Form 427 April 2020Stock Option (right to buy) · traded 23 April 2020 · filed 27 April 2020
- was granted 35,000 shares of Anaptysbio (a derivative holding)SEC Form 411 February 2019Employee Stock Option (Right to Buy) · traded 8 February 2019 · filed 11 February 2019
- exercised options over 37,000 shares of AnaptysbioSEC Form 44 December 2018Common Stock · traded 3 December 2018 · filed 4 December 2018
- ▼ sold on the open market 3,554 shares of AnaptysbioSEC Form 44 December 2018Common Stock · traded 3 December 2018 · filed 4 December 2018
- ▼ sold on the open market 18,604 shares of AnaptysbioSEC Form 44 December 2018Common Stock · traded 3 December 2018 · filed 4 December 2018
- ▼ sold on the open market 4,820 shares of AnaptysbioSEC Form 44 December 2018Common Stock · traded 3 December 2018 · filed 4 December 2018
- ▼ sold on the open market 2,298 shares of AnaptysbioSEC Form 44 December 2018Common Stock · traded 3 December 2018 · filed 4 December 2018
- ▼ sold on the open market 6,624 shares of AnaptysbioSEC Form 44 December 2018Common Stock · traded 3 December 2018 · filed 4 December 2018
- ▼ sold on the open market 1,100 shares of AnaptysbioSEC Form 44 December 2018Common Stock · traded 3 December 2018 · filed 4 December 2018
- exercised options over 37,000 shares of Anaptysbio (a derivative holding)SEC Form 44 December 2018Employee Stock Option (Right to Buy) · traded 3 December 2018 · filed 4 December 2018
- was granted 23,000 shares of Anaptysbio (a derivative holding)SEC Form 430 January 2018Employee Stock Option (right to buy) · traded 26 January 2018 · filed 30 January 2018
- was granted 75,000 shares of Anaptysbio (a derivative holding)SEC Form 428 February 2017Employee Stock Option (right to buy) · traded 24 February 2017 · filed 28 February 2017
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.